• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

What Lies Ahead for 2016: The DIA's Annual Report

Article

February 24, 2016.

What Lies Ahead 2016

DIA’s exclusive annual survey catalogs, ranks, and describes trends to watch in biopharmaceutical, device, and related research, development, and regulation, from expert global and regional perspectives, in the year ahead.

Read the article here.

Related Videos
Related Content
Bob Zambon

Organizing Data: Q&A with Bob Zambon

May 1st 2024
Article

The vice president of technology strategy & strategic partnerships at Syneos Health discusses how new digital technologies are changing the ways that data is collected, shared, analyzed.

Nancy Dreyer

What Impact is AI Having on the Collection and Analysis of RWE?

April 25th 2024
Article

AI allows patients, doctors, and payers to make informed decisions based on evidence at a much faster pace.

Abid Rahman

Will Synthetic, AI-Based Digital Humans Change Pharma and Life Sciences? Q&A with Abid Rahman, SVP Innovation, EVERSANA

April 19th 2024
Article

Rahman discusses the new opportunities that digital twins present to researchers.

UniDoc

UniDoc Brings AI-Powered Health Cube to Alaska

April 17th 2024
Article

The Health Cube will increase remote and virtual care options for populations living in remote areas.

Riccardo Butta

At-Home Patients and AI: Q&A with Riccardo Butta

April 16th 2024
Article

Butta discusses how new technologies are being implemented in at-home devices.

Say Hello to Flexible: Reimagining the Patient Journey

Say Hello to Flexible: Reimagining the Patient Journey

April 15th 2024
Article

Through embracing connected and tech-enabled services and devices, new avenues and opportunities exist for greater clinical trial flexibility in drug research.